These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20513561)
21. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Pirelli KJ; Pietz BC; Johnson ST; Pinder HL; Bellissimo DB Prenat Diagn; 2010 Dec; 30(12-13):1207-12. PubMed ID: 21072752 [TBL] [Abstract][Full Text] [Related]
22. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy. Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918 [TBL] [Abstract][Full Text] [Related]
30. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication]. Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH Ugeskr Laeger; 2006 Jun; 168(26-32):2568-70. PubMed ID: 16824414 [TBL] [Abstract][Full Text] [Related]
31. Is antibody screening in Rh (D)-positive pregnant women necessary? Lurie S; Eliezer E; Piper I; Woliovitch I J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320 [TBL] [Abstract][Full Text] [Related]
33. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007 [TBL] [Abstract][Full Text] [Related]
34. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380 [TBL] [Abstract][Full Text] [Related]
35. Prenatal determination of fetal blood group status. Avent ND; Finning KM; Martin PG; Soothill PW Vox Sang; 2000; 78 Suppl 2():155-62. PubMed ID: 10938946 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD. Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165 [TBL] [Abstract][Full Text] [Related]
37. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn]. Miquel E; Cavelier B; Bonneau JC; Rouger P Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293 [TBL] [Abstract][Full Text] [Related]
38. [Fetal DNA in maternal blood]. Rijnders RJ; Christiaens GC; de Haas M; van der Schoot CE Ned Tijdschr Geneeskd; 2004 Jan; 148(4):170-4. PubMed ID: 14974307 [TBL] [Abstract][Full Text] [Related]